Paul B Watkins

7PUBLICATIONS
55CO-AUTHORS
Metabolomic chemistryBiomolecular modelling and designMolecular medicineQuery processing and optimisationCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 16, 2026
Quantitative Systems Toxicology Modeling with DILIsym to Support Phase 3 Dose Selection for Fezolinetant.

Jace C Nielsen, Jeffrey L Woodhead, Brett A Howell

|Feb 25, 2025
Assessment of liver injury potential of investigational medicines in drug development.

Naga Chalasani, Paul H Hayashi, Debra Luffer-Atlas

|Nov 04, 2024
Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities.

Sean Hammond, Xiaoli Meng, Jane Barber

|Oct 30, 2023
An approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges.

Karamarie Fecho, Chris Bizon, Tursynay Issabekova

|May 13, 2022
Comparing the Liver Safety Profiles of 4 Next-Generation CGRP Receptor Antagonists to the Hepatotoxic CGRP Inhibitor Telcagepant Using Quantitative Systems Toxicology Modeling.

Jeffrey L Woodhead, Scott Q Siler, Brett A Howell

|Aug 05, 2020
Quantitative Systems Toxicology Modeling Predicts that Reduced Biliary Efflux Contributes to Tolvaptan Hepatotoxicity.

James J Beaudoin, William J Brock, Paul B Watkins

Pageof 2

Frequent Collaborators

1 joint publications

James J Beaudoin

1 joint publications

William J Brock

1 joint publications

Kim L R Brouwer

1 joint publications

Karamarie Fecho